5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
-8.74%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$372M
AUM Growth
+$372M
(-29%)
Cap. Flow
-$24.8M
Cap. Flow
% of AUM
-6.67%
Top 10 Holdings %
Top 10 Hldgs %
78.05%
Holding
23
New
2
Increased
2
Reduced
5
Closed
2
Top Buys
| 1 |
AnaptysBio
ANAB
|
$11.1M |
| 2 |
Avidity Biosciences
RNA
|
$6.1M |
| 3 |
FibroGen
FGEN
|
$3.61M |
| 4 |
Disc Medicine
IRON
|
$1.27M |
Top Sells
| 1 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$28M |
| 2 |
Viridian Therapeutics
VRDN
|
$5.4M |
| 3 |
scPharmaceuticals
SCPH
|
$4.3M |
| 4 |
FVAM
5:01 Acquisition Corp. Class A Common Stock
FVAM
|
$3.65M |
| 5 |
Arvinas
ARVN
|
$2.74M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CINC
1
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $60.7M | 16.31% | 4,937,646 | – | – |
|
2
Entrada Therapeutics
TRDA
$208M
| $59.6M | 16.02% | 4,408,379 | – | – |
|
3
Vor Biopharma
VOR
$250M
| $42.3M | 11.37% | 6,361,723 | – | – |
|
4
Rallybio
RLYB
$22.4M
| $24.5M | 6.59% | 3,730,724 | – | – |
|
5
IDEAYA Biosciences
IDYA
$2.15B
| $21.7M | 5.84% | 1,196,298 | – | – |
|
|
PEAR
6
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
| $19.8M | 5.31% | 16,744,113 -159,490 | -0.9% | -$188K |
|
|
7
scPharmaceuticals
SCPH
$295M
| $19.6M | 5.27% | 2,734,852 -600,000 | -18% | -$4.3M |
|
8
Crinetics Pharmaceuticals
CRNX
$2.92B
| $15.8M | 4.24% | 862,286 | – | – |
|
|
9
Avidity Biosciences
RNA
$5.99B
| $14.8M | 3.97% | 665,555 +275,000 | +70% | +$6.1M |
|
|
10
Disc Medicine
IRON
$2.07B
| $11.7M | 3.15% | 588,442 +63,942 | +12% | +$1.27M |
|
|
11
AnaptysBio
ANAB
$569M
| $11.1M | 2.98% | +357,733 | New | +$11.1M |
|
|
12
Arvinas
ARVN
$568M
| $10.9M | 2.94% | 320,000 -80,000 | -20% | -$2.74M |
|
|
IMPL
13
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $10.8M | 2.91% | 2,884,791 | – | – |
|
14
Cogent Biosciences
COGT
$1.69B
| $9.14M | 2.46% | 790,440 | – | – |
|
|
15
Viridian Therapeutics
VRDN
$1.5B
| $8.76M | 2.35% | 300,000 -184,891 | -38% | -$5.4M |
|
|
ISEE
16
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.23M | 2.21% | 384,626 -124,221 | -24% | -$2.66M |
|
17
Pharvaris
PHVS
$1.39B
| $6.61M | 1.78% | 587,600 | – | – |
|
18
Janux Therapeutics
JANX
$1.37B
| $5.88M | 1.58% | 446,266 | – | – |
|
19
Q32 Bio
QTTB
$20.9M
| $5.72M | 1.54% | 4,535,919 | – | – |
|
|
20
FibroGen
FGEN
$47.8M
| $3.61M | 0.97% | +225,583 | New | +$3.61M |
|
21
Cidara Therapeutics
CDTX
$1.66B
| $858K | 0.23% | 1,134,511 | – | – |
|
|
AKUS
22
DELISTED
Akouos, Inc. Common Stock
AKUS
| – | – | -4,135,784 | Closed | -$28M |
|
|
FVAM
23
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
| – | – | -365,126 | Closed | -$3.65M |
|